Gabriele Marco Antonio Cerrone
Non-Executive ChairmanMr. Gabriele Marco Antonio Cerrone, MBA, is the Founder of Tiziana Life Sciences Ltd and has been its Executive Chairman and Director since April 24, 2014 and served as its Interim Chief Executive Officer until August 19, 2024. He is Executive Chairman of the Board at Accustem Sciences, Inc. and has been its Director since March 2021 and AccuStem Sciences Limited. He serves as Non-Executive Chairman of OKYO Pharma Limited since January 7, 2021. He is Founder and Executive Chairman of GENSIGNIA. Mr. Cerrone is sole General Partner of Panetta Partners, Ltd. He is a Co-Founder and Chairman of Arna Therapeutics and BioVitas Capital. He served as Consultant of Callisto Pharmaceuticals, Inc. since January 2005 and Xenomics Inc. since June 27, 2005. He co-founded FermaVir Pharmaceuticals. He has a successful track record and extensive experience in the seeding, financing and restructuring of biotechnology companies. He has founded eight biotech companies in the fields of oncology, infectious disease and molecular diagnostics. From March 1999 to January 2005, he served as Senior Vice President of Investments of Oppenheimer & Co. Inc. He served as Consultant of Used Kar Parts Inc. From March 1998 to March 1999, he served as Managing Director at Investments at Barington Capital LP. and from June 1994 to February 1998, he served as Senior Vice President of Investments at Blair & Company. Mr. Cerrone served as Chairman of FermaVir Pharmaceuticals, L.L.C. since August 16, 2005 until September 2007; Synergy Pharmaceuticals, Inc. from July 2008 to September 30, 2013 and Pawfect Foods Inc. since July 2008. He served as Chairman of Callisto Pharmaceuticals, Inc. (formerly, Webtronics Inc.) since May 2003. He is Co-Founder of Rasna Therapeutics Inc. a company focused on the development of therapeutics for leukaemias; Co-Founder of Hepion Pharmaceuticals, Inc.; Executive Chairman and Co-Founder of Gensignia Life Sciences, Inc. a molecular diagnostics company focused on oncology using microRNA technology; and Non-Executive Chairman and Founder of Accustem Sciences Limited. He served as a Co-Chairman of TrovaGene Inc. (alternatively, Xenomics Inc./ formerly Used Kar Parts Inc.) since July 8, 2005. Mr. Cerrone served as an Acting Chairman of the Board at Callisto Pharmaceuticals Inc. Mr. Cerrone co-founded Cardiff Oncology, Inc. an oncology company and served as its Co-Chairman; he was a co-founder of Synergy Pharmaceuticals, Inc. and Callisto Pharmaceuticals, Inc. He serves as a Director of the following privately-held companies: Callisto Pharmaceuticals Inc. and Macro Holdings LLC. He served as a Director of TrovaGene Inc. since February 2010; Venus Beauty Supply Inc.; Pawfect Foods Inc. since July 2008; Used Kar Parts Inc. and Venus Beauty Supply Inc.; SIGA Technologies Inc. from April 19, 2001 to May 2003; Synergy Pharmaceuticals, Inc. since September 30, 2013 and Inhibitex Inc. from September 19, 2007 to February 13, 2012. Mr. Cerrone is a 1994 graduate of New York University's Stern School of Business with a Master in Business Administration (MBA).
公司职务
- 公司名称OKYO Pharma Limited股票代码OKYO职务Non-Executive Chairman共事同僚
- RJRobert J. DempseyCEO & Executive Director
- GMGabriele Marco Antonio CerroneNon-Executive Chairman
- KSKeeren ShahChief Financial Officer
- RPRajkumar PatilChief Scientific Officer
- GSGary S. JacobChief Development Officer & Director
- FMFlavio MantelliChief Medical Officer
- WJWilly Jules SimonSenior Independent Non-Executive Director
- JPJohn Patrick BrancaccioIndependent Non-Executive Director
- 公司名称Tiziana Life Sciences Ltd股票代码TLSA职务Founder & Executive Chairman共事同僚
- KSKeeren ShahCOO & CFO
- IRIvor R. ElrifiCEO & Executive Director
- WEWilliam Edward TenteChief Regulatory Officer
- RKRichard K. KimChief Medical Officer
- NFNapoleone FerraraMember of Scientific Advisory Board
- WJWilly Jules SimonIndependent Non-Executive Director
- JPJohn Patrick BrancaccioIndependent Non-Executive Director
- 公司名称AccuStem Sciences, Inc.股票代码ACUT职务Executive Chairman of the Board共事同僚
- GMGabriele Marco Antonio CerroneExecutive Chairman of the Board
- WEWendy E. BlosserCEO & Director
- JFJeff FenstererChief Operating Officer
- JFJoe FlanaganChief Business Officer
- KSKeeren ShahChief Financial Officer
- JPJohn Patrick BrancaccioIndependent Director
- WJWilly Jules SimonIndependent Director
- SCSean C. McDonaldDirector
